Tag: ImmunoPrecise Antibodies

February 23, 2021

5 Biggest Canadian Pharma Stocks

The Canadian pharmaceutical market is the 10th largest in the world. What are the biggest pharma stocks on the TSX and...
March 2, 2020

ImmunoPrecise Announces AI Collaboration with EVQLV for Coronavirus

IMMUNOPRECISE and EVQLV are collaborating on accelerating the global effort to develop lead vaccine candidates against the SARS-CoV-2 virus.
May 1, 2019

BBHIC 2019, Day 2: Notes From the Floor

The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
September 18, 2017

ImmunoPrecise Awarded First Commercial Humanized Antibody Project

ImmunoPrecise announced it was awarded the first commercial humanizing antibody project from an undisclosed biotech company.
August 29, 2017

ImmunoPrecise Announces R&D Positive Results Using the OmniAb Platform

ImmunoPrecise Antibodies announced it is now an approved contract research organization for the development of human monoclonal antibodies with the...
August 3, 2017

ImmunoPrecise Announces Expansion into Humanizing Technologies

ImmunoPrecise Antibodies announced its working towards delivering humanized monoclonal antibodies.
July 24, 2017

ImmunoPrecise Increases Financing to $5.1 million

Immunoprecise Antibodies announced it increased a previously announced non-brokered private placement financing.